APA

Hermanides R. S., Heestermans A. A. C. M., Ten Berg J. M., Gosselink A. T. M., Ottervanger J. P., van Houwelingen K. G., Kolkman J. J. E., Stella P. R., Dill T., Hamm C. & van 't Hof A. W. J. (20110309). High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. : Heart (British Cardiac Society).

Chicago

Hermanides R S, Heestermans A A C M, Ten Berg J M, Gosselink A T M, Ottervanger J P, van Houwelingen K G, Kolkman J J E, Stella P R, Dill T, Hamm C and van 't Hof A W J. 20110309. High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. : Heart (British Cardiac Society).

Harvard

Hermanides R. S., Heestermans A. A. C. M., Ten Berg J. M., Gosselink A. T. M., Ottervanger J. P., van Houwelingen K. G., Kolkman J. J. E., Stella P. R., Dill T., Hamm C. and van 't Hof A. W. J. (20110309). High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. : Heart (British Cardiac Society).

MLA

Hermanides R S, Heestermans A A C M, Ten Berg J M, Gosselink A T M, Ottervanger J P, van Houwelingen K G, Kolkman J J E, Stella P R, Dill T, Hamm C and van 't Hof A W J. High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. : Heart (British Cardiac Society). 20110309.